Eight SEGs in MA-K, RPLP2, RPS16, MRPS16, SSPN, CD52, VPREB3, CCDC82, and ANKRD37, were identified as promising prognostic biomarkers of human DLBCL. The gene discussed is CCDC82; the disease is diffuse large B-cell lymphoma.